Trial · NCT05584605
Perfusion Augmentation Through Exercise
NCT05584605, Not applicable, Unknown, University of Zurich
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Perfusion Augmentation Through Exercise. Trials, record NCT05584605. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05584605
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Perfusion Augmentation Through Exercise
- NCT number
- NCT05584605
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 40 participants, estimated
- Lead sponsor
- University of Zurich
- Conditions
- Stroke, Ischemic
- Interventions
- Aerobic treadmill training, Stretching exercise
- First posted
- 2022-10-18
- Last updated
- 2022-10-18
Source ClinicalTrials.gov
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Brain imaging - cerebrovascular reactivity (CVR) by BOLD-fMRI | post-intervention (12 weeks) | Functional brain tissue perfusion and tissue at risk based on cerebrovascular reactivity by blood oxygenation-level dependent functional magnetic resonance imaging (BOLD-fMRI), measured as the percentage BOLD signal change /mmHg CO2. |
| Secondary | Brain imaging - intravoxel incoherent motion (IVIM) | post-intervention (12 weeks) | Functionality of brain microvasculature by measuring diffusion and perfusion components of tissue based on intravoxel incoherent motion |
| Secondary | Brain imaging - NOVA-qMRI | post-intervention (12 weeks) | Blood flow velocity based on non-invasive optimal vessel analysis quantitative magnetic resonance imaging |
| Secondary | Brain imaging - Lesion volume | post-intervention (12 weeks) | based on 3D T1 weighted imaging, 3D Fluid-Attenuated Inversion Recovery (FLAIR), Diffusion-Eighted Imaging (DWI) |
| Secondary | Brain imaging - Collateral status | post-intervention (12 weeks) | Collateral status based on 3D time of flight angiography (TOF) |
| Secondary | Exercise stress testing | post-intervention (12 weeks) | Cycle ergometer testing with spirometry |
| Secondary | Six-Minute Walk Test (6MWT) | post-intervention (12 weeks) + follow-up (+3 months) | Functional walking capacity in meters |
| Secondary | Ten-Meter Walk Test (10MWT) | post-intervention (12 weeks) + follow-up (+3 months) | Walking speed in m/s |
| Secondary | Fugl-Meyer Assessment of the Lower Extremity (FMMA-LE) | post-intervention (12 weeks) + follow-up (+3 months) | Stroke-specific motor impairment index to assess lower limb motor function with a total score ranging from 0 to 34 and higher scores indicating better performance. |
| Secondary | Motricity Index of the Lower Extremity (MI-LE) | post-intervention (12 weeks) + follow-up (+3 months) | Muscle strength assessment of three major muscle groups of the lower extremity with a total score ranging from 0 to 100 and higher scores indicating better performance. |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Corsi Block-Tapping Test | Secondary outcome | ConductCognition |
| Digit Span Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Verbal Learning | Secondary outcome | ConductCognition |
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05584605
GET https://conductscience.org/api/trials/v1/NCT05584605/registered